The effect of levocabastine hydrochloride on human Tenon’s capsule fibroblasts: Inhibition of proliferation, suppression of DNA synthesis and induction of apoptosis

References

• Arakawa K, Tonooka M, Goto H, Sakamoto K. Membrane stabilizing action of NCO-650 and its congeners. Jpn J Pharmacol. 1984; 36:311–318.
   PubMedGoogle Scholar
• Ujiie A, Kojima M, Naito J, Nakazawa M, Koda A. Effect of N-5′ on histamine release from rat peritoneal exudates cells induced by calcium ionophore and ATP. Jpn J Pharmacol. 1984; 34:9–14.
   PubMedGoogle Scholar
• Oshima T, Kurosaka D, Kato K, Kurosaka H, Mashima Y, Tanaka Y, Tajima S. Tranilast inhibits cell proliferation and collagen synthesis by rabbit corneal and Tenon’s capsule fibroblasts. Curr Eye Res. 2000; 20:283–286.
   PubMed Web of Science ®Google Scholar
• Radermecker M. Inhibition of allergen-mediated release from human cells by ketotifen and oxatomide. Comparison with other H1 antihistamines. Respiration. 1981; 41:45–55.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Iwaki M, Imagawa M, Takeuchi M. Anti-allergic drugs inhibit the proliferation of bovine lens epithelial cells in culture. J Jpn Ophthalmol Soc. 2001; 105:517–523.
   PubMedGoogle Scholar
• Kitayoshi H, Matsumoto I, Masuoka K. Clinical effect of ketotifen fumarate to keroid and pachyscar [Japanese]. J New Remedies Clin. 1996; 45:128–138.
   Google Scholar
• Suzawa H, Kikuchi S, Arai N, Noda A. The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblast. Jpn J Pharmacol. 1992; 60:91–96.
   PubMedGoogle Scholar
• Fukuyama J, Miyazawa K, Hamano S, Ujiie A. Inhibitory effects of tranilast on proliferation, migration, and collagen synthesis of human vascular smooth muscle cells. Can J Physiol Pharmacol. 1996; 74:80–84.
   PubMed Web of Science ®Google Scholar
• Furukawa H, Nakayasu K, Gotoh T, Watanabe Y, Takano T, Ishikawa T, Kanai A. Effect of topical tranilast and corticosteroids on subepithelial haze after photorefractive keratectomy in rabbits. J Refract Surg. 1997; 13(5 suppl):S457–S458.
   PubMed Web of Science ®Google Scholar
• Tobari I, Iwaki Y, Miyake K. Effect of tranilast eyedrops in preventing posterior capsule opacification: preliminary report. J Cataract Refract Surg. 1999; 25:1394–1399.
   PubMed Web of Science ®Google Scholar
• Chihara E, Ochiai H, Dong T. Effect of TGF-β1 blocker tranilast on filtering blebs after glaucoma surgery [Japanese]. Folia Ophthalmol Jpn. 1999; 50:260–266.
   Google Scholar
• Costa VP, Spaeth GL, Eiferman RA, Orengo-Nania S. Wound healing modulation in glaucoma filtration surgery. Ophthalmic Surg. 1993; 24:152–170.
   PubMedGoogle Scholar
• Dechant KL, Goa Kl. Levocabastine; a review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis. Drugs. 1991; 41:202–224.
   PubMed Web of Science ®Google Scholar
• Akiyoshi M, Shigeoka T, Torii S, Maki E, Enomoto S, Takahashi H, Hirano F. Pharmacological and clinical properties of levocabastine hydrochloride (eye drop and nasal spray), a selective H1 antagonist [Japanese]. Folia Pharmacol Jpn. 2002; 119:175–184.
   PubMedGoogle Scholar
• Uchino E, Kadonosono K. Acute asthma attack caused by ophthalmic application of antiallergic agents. Jpn J Ophthalmol. 2004; 48:475–477.
   PubMed Web of Science ®Google Scholar
• Leonardi A, Radice M, Fregona IA, Abatangelo G, Secchi AG. Histamine effects on conjunctival fibroblasts from patients with vernal conjunctivitis. Exp Eye Res. 1999; 68:739–746.
   PubMed Web of Science ®Google Scholar
• Inagaki N, Miura T, Koda A. Active cutaneous anaphylaxis (ACA) in the mouse ear. Jpn J Pharmacol. 1992; 59:201–208.
   PubMedGoogle Scholar
• Schoch C. Effects of ketotifen 0.025%,and lodoxamide 0.1% on eosinophil infiltration into the guinea pig conjunctiva in a model of allergic conjunctivitis. J Ocul Pharmacol Ther. 2003; 19:153–159.
   PubMed Web of Science ®Google Scholar
• Nakagami T. Appearance and control of stem cell factor on the ocular surface constructing cells. Report of Grant-in- Aid for Scientific Research, Grant-in-Aid for Scientific Research (C) 14571664. Tokyo, Japan: Japan Society for the Promotion of Science. 2002–2003.
   Google Scholar
• Maita E, Sato M, Yamaki K. Effect of tranilast on matrix metalloproteinase-1 secretion from human gingival fibroblasts in vitro. J Periodontol. 2004; 75:1054–1056.
   PubMed Web of Science ®Google Scholar
• Martin J, Kelly DJ, Mifsud SA, Zhang Y, Cox AJ, See F, Krum H, Wilkinson-Berka J, Gilbert RE. Tranilast attenuates cardiac matrix deposition in experimental diabetes: role of transforming growth factor-beta. Cardiovasc Res. 2005; 65:694–701.
   PubMed Web of Science ®Google Scholar
• Ochiai H, Ochiai Y, Chihara F. Tranilast inhibits TGF-A1 secretion without affecting its mRNA levels in conjunctival cells. Kobe J Med Sci. 2001; 47:203–209.
   PubMedGoogle Scholar
• Shimizu T, Kanai K, Asano K, Hisamitsu T, Suzaki H. Suppression of matrix metalloproteinase production in nasal fibroblast by traninast, an antiallergic agent, in vivo. Mediators Inflamm. 2005; 14:150–159.
   Google Scholar
• Inoue H, Ohshima H, Kono H, Yamanaka M, Kubota T, Aihara M, Hiroi T, Yago N, Ishida H. Suppressive effects of tranilast on the expression of inducible cyclooxygenase (COX2) in interleukin-1beta-stimulated fibroblast. Biochem Pharmacol. 1997; 53:1941–1944.
   PubMed Web of Science ®Google Scholar
• Leonardi A, De Franchis G, De Paoli M, Fregona I, Plebani M, Secchi A. Histamine-induced cytokine production and ICAM-a expression in human conjunctival fibroblasts. Curr Eye Res. 2002; 25:189–196.
   PubMed Web of Science ®Google Scholar
• Levi-Schaffer, Rubinchik E. Mast cell/fibroblast interactions. Clin Exp Allergy. 1994; 24:1016–1021.
   PubMed Web of Science ®Google Scholar
• Solomon A, Shmilowich R, Shasha D, Frucht-Pery J, Pe’er J, Bonini S, Levi-Schaffer F. Conjunctival fibroblasts enhance the survival and functional activity of peripheral blood eosinophils in vitro. Invest Ophthalmol Vis Sci. 2000; 41:1038–1044.
   PubMed Web of Science ®Google Scholar
• Mikko M, Fredriksson K, Wahlstrom J, Eriksson P, Grunewald P, Skold CM. Human T cells stimulate fibroblast-mediated degradation of extracellular matrix in vitro. Clin Exp Immunol. 2008; 151:317–325.
   PubMed Web of Science ®Google Scholar
• Rubinchick E, Levi-Schaffer F. Mast cells and fibroblasts: two interacting cells. Int J Clin Lab Res. 1994; 24:139–142.
   PubMedGoogle Scholar
• Flavell SJ, Hou TZ, Lax S, Filer AD, Salmon M, Buckley CD. Fibroblasts as novel therapeutic targets in chronic inflammation. Br J Pharmacol. 2008;153(suppl 1):S241–S246.
   PubMedGoogle Scholar